Serum lipoprotein(a) levels and diabetic nephropathy among Japanese patients with type 2 diabetes mellitus

Journal of Diabetes and its Complications

Volumn 30, Issue 5, 2016, Pages 923-927

  Senba, Hidenori ^a   Furukawa, Shinya ^a,b   Sakai, Takenori ^c   Niiya, Tetsuji ^d   Miyake, Teruki ^a   Yamamoto, Shin ^a   Ueda, Teruhisa ^e   Torisu, Masamoto ^f   Minami, Hisaka ^g   Miyaoka, Hiroaki ^h   Onji, Morikazu ⁱ   Tanaka, Keiko ^a,b   Matsuura, Bunzo ^a   Tanigawa, Takeshi ^j   Hiasa, Yoichi ^a   Miyake, Yoshihiro ^a,b  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b EHIME UNIVERSITY HOSPITAL   (Japan)

^c Yawatahama City General Hospital   (Japan)

^d Matsuyama Shimin Hospital   (Japan)

^e EHIME PREFECTURAL CENTRAL HOSPITAL   (Japan)

^f Saiseikai Saijo Hospital   (Japan)

^g Ehime Prefecture Niihama Hospital   (Japan)

^h Saiseikai Matsuyama Hospital   (Japan)

ⁱ Imabari Saiseikai Hospital   (Japan)

^j JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

Albuminuria; Diabetes; Diabetic nephropathy; Kidney disease; Lipoprotein(a); Lipoproteins

Indexed keywords

CHOLESTEROL; CREATININE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DISEASE DURATION; DRINKING; DYSLIPIDEMIA; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; JAPANESE (PEOPLE); LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX; SMOKING; ALBUMINURIA; BLOOD; CLINICAL TRIAL; COMPLICATION; CROSS-SECTIONAL STUDY; JAPAN; KIDNEY FAILURE; MIDDLE AGED; PATHOPHYSIOLOGY; PREVALENCE; SEVERITY OF ILLNESS INDEX; UPREGULATION; URINE; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ALBUMINURIA; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; JAPAN; LIPOPROTEIN(A); MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY; SEVERITY OF ILLNESS INDEX; UP-REGULATION; YOUNG ADULT;

EID: 84959482503     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2016.02.006     Document Type: Article

References (42)

1. K. Berg A new serum type system in man: The Lp system Acta Pathologica et Microbiologica Scandinavica 59 1963 362 382
2. R. Chandni, and K.P. Ramamoorthy Lipoprotein(a) in type 2 diabetic subjects and its relationship to diabetic microvascular complications World Journal of Diabetes 3 2012 105 109
3. C. Cobbaert, and H. Kesteloot Serum lipoprotein(a) levels in racially different populations American Journal of Epidemiology 136 1992 441 449
4. M.G. De Sain-Van Der Velden, D.J. Reijngoud, G.A. Kaysen, M.M. Gadellaa, H. Voorbij, and F. Stellaard T.J. Rabelink Evidence for increased synthesis of lipoprotein(a) in the nephrotic syndrome Journal of the American Society of Nephrology 9 1998 1474 1481
5. R. Deepa, A. Mohan, M. Rema, S.P. Haranath, G. Saravanan, and V. Mohan Lipoprotein(a) in South Indian type 2 diabetic subjects in relation to diabetic vascular complications Journal of the Association of Physicians of India 50 2002 657 661
6. M.E. Frischmann, F. Kronenberg, E. Trenkwalder, J.R. Schaefer, H. Schweer, and B. Dieplinger H. Dieplinger In vivo turnover study demonstrates diminished clearance of lipoprotein(a) in hemodialysis patients Kidney International 71 2007 1036 1043
7. J. Galle, P. Stunz, P. Schollmeyer, and C. Wanner Oxidized LDL and lipoprotein(a) stimulate renin release of juxtaglomerular cells Kidney International 47 1995 45 52
8. J. Galle, A. Heinloth, S. Schwedler, and C. Wanner Effect of HDL and atherogenic lipoproteins on formation of O2- and renin release in juxtaglomerular cells Kidney International 51 1997 253 260
9. J. Galle, R. Schneider, A. Heinloth, C. Wanner, P.R. Galle, and E. Conzelmann K. Heermeier Lp(a) and LDL induce apoptosis in human endothelial cells and in rabbit aorta: Role of oxidative stress Kidney International 55 1999 1450 1461
10. S. Greiber, M. Kreusel, H. Pavenstädt, P. Schollmeyer, and C. Wanner Lipoprotein(a) induces glomerular superoxide anion production Nephrology, Dialysis, Transplantation 12 1997 1330 1335
11. S.M. Haffner, P.A. Morales, M.K. Gruber, H.P. Hazuda, and M.P. Stern Cardiovascular risk factors in non-insulin-dependent diabetic subjects with microalbuminuria Arteriosclerosis & Thrombosis 13 1993 205 210
12. M. Haneda, K. Utsunomiya, D. Koya, T. Babazono, T. Moriya, and H. Makino K. Shide A new Classification of Diabetic Nephropathy 2014: A report from Joint Committee on Diabetic Nephropathy Journal of Diabetes Investigation 6 2015 242 246
13. B.J. Heesen, B.H. Wolffenbuttel, P.B. Leurs, J.P. Sels, P.P. Menheere, and S.E. Jäckle-Beckers A.C. Kruseman Lipoprotein(a) levels in relation to diabetic complications in patients with non-insulin-dependent diabetes European Journal of Clinical Investigation 23 1993 580 584
14. C. Hernández, R. Simó, P. Chacón, A. Segarra, D. Lopez, and J. Mesa Relationship between lipoprotein(a) phenotypes and albumin excretion rate in non-insulin-dependent diabetes mellitus: Protective effect of 'null' phenotype? European Journal of Clinical Investigation 27 1997 497 502
15. T. Hiraga, T. Kobayashi, M. Okubo, K. Nakanishi, T. Sugimoto, Y. Ohashi, and T. Murase Prospective study of lipoprotein(a) as a risk factor for atherosclerotic cardiovascular disease in patients with diabetes Diabetes Care 18 1995 241 244
16. A.B. Irish, L.A. Simons, E. Savdie, J.M. Hayes, and J. Simons Lipoprotein(a) levels in chronic renal disease states, dialysis and transplantation Australian and New Zealand Journal of Medicine 22 1992 243 248
17. Japan Nephrology Society Clinical practice guidebook for diagnosis and treatment of chronic kidney disease 2012 Nippon Jinzo Gakkai Shi 54 2012 1034 1191 (in Japanese)
18. B. Kollerits, M. Auinger, V. Reisig, T. Kästenbauer, A. Lingenhel, and K. Irsigler F. Kronenberg Lipoprotein(a) as a predictor of cardiovascular disease in a prospectively followed cohort of patients with type 1 diabetes Diabetes Care 29 2012 1661 1663
19. F. Kronenberg, and G. Utermann Lipoprotein(a): Resurrected by genetics Journal of Internal Medicine 273 2013 6 30
20. F. Kronenberg, G. Utermann, and H. Dieplinger Lipoprotein(a) in renal disease American Journal of Kidney Diseases 27 1996 1 25
21. J. Lin, M.P. Reilly, K. Terembula, and F.P. Wilson Plasma lipoprotein(a) levels are associated with mild renal impairment in type 2 diabetics independent of albuminuria PloS One 9 2014 e114397
22. Y. Ling, X. Li, Q. Gu, and X. Gao Circulating ApoE level is independently associated with urinary albumin excretion in type 2 diabetic patients Internal Medicine 50 2011 2961 2966
23. J. Loscalzo, M. Weinfeld, G.M. Fless, and A.M. Scanu Lipoprotein(a), fibrin binding, and plasminogen activation Arteriosclerosis 10 1990 240 245
24. S.M. Marcovina, J.J. Albers, E. Wijsman, Z. Zhang, N.H. Chapman, and H. Kennedy Differences in Lp(a) concentrations and apo(a) polymorphs between black and white Americans The Journal of Lipid Research 37 1996 2569 2585
25. J.W. McLean, J.E. Tomlinson, W.J. Kuang, D.L. Eaton, E.Y. Chen, and G.M. Fless R.M. Lawn cDNA sequence of human apolipoprotein(a) is homologous to plasminogen Nature 330 1987 132 137
26. U.F. Mondorf, A. Piiper, M. Herrero, H.G. Olbrich, M. Bender, and W. Gross H. Geiger Lipoprotein(a) stimulates growth of human mesangial cells and induces activation of phospholipase C via pertussis toxin-sensitive G proteins Kidney International 55 1999 1359 1366
27. T. Nagai, T. Tomizawa, and M. Mori Change of lipoprotein(a) and coagulathre or fibrinolytic parameters in diabetic patients with nephropathy Diabetes Care 16 1993 1411 1412
28. M. Oishi, K. Yamazaki, F. Okuguchi, H. Sugimoto, A. Kanatsuka, and A. Kashiwagi Changes in oral antidiabetic prescriptions and improved glycemic control during the years 2002-2011 in Japan (JDDM32) Journal of Diabetes Investigation 5 2014 581 587
29. Q. Qi, and L. Qi Lipoprotein(a) and cardiovascular disease in diabetic patients Journal of Clinical Lipidology 7 2012 397 407
30. J.L. Reverter, M. Sentí, J. Rubiés-Prat, A. Lucas, I. Salinas, and E. Pizarro A. Sanmartí Relationship between lipoprotein profile and urinary albumin excretion in type II diabetic patients with stable metabolic control Diabetes Care 17 1994 189 194
31. N. Rifai, G. Heiss, and K. Doetsch Lipoprotein(a) at birth, in blacks and whites Atherosclerosis 92 1992 123 129
32. S. Rosas, M. Joffe, M. Wolfe, K. Brayman, and D.J. Rader Effects of renal replacement therapy on plasma lipoprotein(a) levels American Journal of Nephrology 28 2008 361 365
33. J. Ruiz, J. Thillet, T. Huby, R.W. James, D. Erlich, and P. Flandre P. Passa Association of elevated lipoprotein(a) levels and coronary heart disease in NIDDM patients. Relationship with apolipoprotein(a) phenotypes Diabetologia 37 1994 585 591
34. K.H. Song, S.H. Ko, H.W. Kim, Y.B. Ahn, J.M. Lee, and H.S. Son H.Y. Son Prospective study of lipoprotein(a) as a risk factor for deteriorating renal function in type 2 diabetic patients with overt proteinuria Diabetes Care 28 2005 1718 1723
35. T. Takegoshi, T. Haba, J. Hirai, C. Kitoh, T. Saga, and Y. Yamazaki H. Mabuchi Alterations of lipoprotein(a) in patients with diabetic nephropathy Atherosclerosis 83 1990 99 100
36. The Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus Report of the committee on the classification and diagnostic criteria of diabetes mellitus Diabetology International 1 2010 2 20
37. The Emerging Risk factors Collaboration Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality JAMA 302 2009 412 423
38. J. Thiery, B. Ivandic, G. Bahlmann, A.K. Walli, and D. Seidel Hyperlipoprotein(a)aemia in nephrotic syndrome European Journal of Clinical Investigation 26 1996 316 321
39. R. Toro, E. Segura, J.M. Nuñez-Cortes, J.C. Pedro-Botet, M. Quezada-Feijoo, and A. Mangas Relationship between lipoprotein(a) and micro/macro complications in type 2 diabetes mellitus: A forgotten target Journal of Geriatric Cardiology 12 2015 93 99
40. C.H. Tseng Differential dyslipidemia associated with albuminuria in type 2 diabetic patients in Taiwan Clinical Biochemistry 42 2009 1019 1024
41. G. Utermann The mysteries of lipoprotein(a) Science 246 1989 904 910
42. H. Yokoyama, K. Kawai, and M. Kobayashi Microalbuminuria is common in Japanese type 2 diabetic patients - a nationwide survey from the Japan Diabetes Clinical Data Management Study Group (JDDM 10) Diabetes Care 30 2007 989 992